Searched for
RAKESH BAMZAI
Covid-19: Key drugs, steroids in short supply; input costs surgeTwo anti-virals — Remdesivir and Favipiravir — and Tocilizumab injections being used in the Covid-19 treatment have witnessed massive short...- Ramping production of Remdesivir to meet demand: Pharma firmsA Zydus Cadila spokesperson said, "The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing...
- Mylan launches remdesivir in India under the brand name DESREM for Covid-19 treatmentThe drug is approved for the treatment of suspected or laboratory confirmed incidences of Covid-19 in adults and children hospitalised with...
- Mylan wants to capture chronic Hep B marketThe drug was approved in India in November this year and is the “first” to be approved in eight years for the management of this infection ...
- Biocon posts 15% rise in revenue, names new CEOBiocon, the country's largest biotech company, reported a 15% rise in fourth-quarter revenue to 746 crore, helped by a 17% rise in sales at...
- Pricing of imported drugs under regulatory scannerNPPA has initiated a process to end the freedom enjoyed by drug makers to fix the retail price of their imported medicines.
- Biocon Q4 net up 25.04% at Rs 101 cr, to hire 1,000Biocon Ltd reported a 25 percent rise in fourth-quarter profit as strong sales of its biopharmaceutical drugs helped offset muted sales at ...
- Biocon seals Rs 1,550 cr pact with PfizerThe agreement includes the commercialisation of Biocon’s biosimilar versions of insulin and insulin analog products: recombinant human insu...
- Wockhardt, Biocon under NPPA scannerWockhardt and Biocon have come under the drug price regulator National Pharmaceutical Pricing Authority (NPPA) scanner for allegedly violat...
- Biocon launches breast cancer drugBiotech company Biocon said it has launched the drug Abraxane, used in the treatment of breast cancer.
- Biocon forays into nephrology spaceThe new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category.
Load More
